Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia (1990)
- Authors:
- USP affiliated authors: BERNIK, MARCIA MARTINS SILVEIRA - HU ; QUINTAO, EDER CARLOS ROCHA - FM
- Unidades: HU; FM
- Assunto: ENDOCRINOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Anais
- Conference titles: Congresso Panamericano de Endocrinologia
-
ABNT
NAKANDAKARE, E et al. Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. 1990, Anais.. Recife: Hospital Universitário, Universidade de São Paulo, 1990. . Acesso em: 15 maio 2024. -
APA
Nakandakare, E., Garcia, R. C., Kawakami, R. R., Bernik, M. M. S., Neves, M. Q. T. S., & Quintão, E. C. da R. (1990). Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. In Anais. Recife: Hospital Universitário, Universidade de São Paulo. -
NLM
Nakandakare E, Garcia RC, Kawakami RR, Bernik MMS, Neves MQTS, Quintão EC da R. Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. Anais. 1990 ;[citado 2024 maio 15 ] -
Vancouver
Nakandakare E, Garcia RC, Kawakami RR, Bernik MMS, Neves MQTS, Quintão EC da R. Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia. Anais. 1990 ;[citado 2024 maio 15 ] - Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Artificial chylomicrons metabolism as a probe for the plasma lipid lowering drug action mechanism
- Disturbances of lipid metabolism in hypothyroidism studied by artificial chylomicrons
- Long term treatment of hypercholesterolemia with simvastatin
- Ldl-apheresis in the treatment of one patient with homozygous familial hypercholesterolemia
- Fitoesterol esterificado na dieta diminui a concentração plasmática de colesterol e de CETP relacionada ao polimorfismo 1405V da CETP
- Plasma cholesterol and CETP concentrations are lowered by dietary phytosterol ester but only the cholesterol variation related to the CETP 1405V polymorphism
- Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Eficiencia dos esteres de fitoesterois alimentares na reducao dos lipides plasmaticos em hipercolesterolemicos moderados
- The age-related rise of plasma cholesterol in humans is not caused by a cell removal defect of LDL particles: 'in vitro' studies in peripheral mononuclear blood cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas